Published in J Antimicrob Chemother on December 01, 1985
Pharmacokinetics of ticarcillin and clavulanic acid (timentin) in relation to renal function. Antimicrob Agents Chemother (1986) 0.81
Bone penetration of amoxicillin and clavulanic acid evaluated by population pharmacokinetics and Monte Carlo simulation. Antimicrob Agents Chemother (2009) 0.79
Pharmacokinetics of ciprofloxacin after oral and parenteral administration. Antimicrob Agents Chemother (1985) 4.07
Pharmacokinetics of ofloxacin after parenteral and oral administration. Antimicrob Agents Chemother (1987) 3.09
[Azlocillin and mezlocillin: two new semisynthetic acylureido-penicillins (author's transl)]. Infection (1977) 2.54
Comparative pharmacokinetics of cephalexin, cefaclor, cefadroxil, and CGP 9000. Antimicrob Agents Chemother (1979) 2.23
Clinical evaluation of a Mycobacterium tuberculosis PCR assay. J Clin Microbiol (1995) 2.19
Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis. Eur Respir J (1996) 2.18
A program for non-linear regression analysis to be used on desk-top computers. Comput Programs Biomed (1980) 2.03
Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administration. Eur J Clin Microbiol (1986) 2.00
Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): evidence for HIV-induced enteropathy. Ann Intern Med (1989) 1.99
67 Ga for tumor scanning. J Nucl Med (1972) 1.97
Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. Chest (1998) 1.95
Reduced enteral absorption of ciprofloxacin in the presence of antacids. Eur J Clin Microbiol (1985) 1.86
High-level sensitivity of quantitative pp65 cytomegalovirus (CMV) antigenemia assay for diagnosis of CMV disease in AIDS patients and follow-up. J Clin Microbiol (1996) 1.81
Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin, and moxifloxacin after single oral administration in healthy volunteers. Antimicrob Agents Chemother (2000) 1.80
Application of the polymerase chain reaction in the diagnosis of pulmonary toxoplasmosis in immunocompromised patients. Eur J Clin Microbiol Infect Dis (1992) 1.71
High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusions. Eur Respir J (2006) 1.64
Respiratory failure in patients undergoing allogeneic hematopoietic SCT--a randomized trial on early non-invasive ventilation based on standard care hematology wards. Bone Marrow Transplant (2011) 1.63
Drug-resistant pulmonary tuberculosis in Berlin, Germany, 1987-1993. Eur Respir J (1995) 1.52
Increased number of alveolar macrophages expressing adhesion molecules of the leukocyte adhesion molecule family in smoking subjects. Association with cell-binding ability and superoxide anion production. Am Rev Respir Dis (1992) 1.49
Hypersensitivity pneumonitis associated with the use of temozolomide. Eur Respir J (2009) 1.47
Comparative pharmacokinetics of cefoperazone and cefotaxime. Clin Ther (1980) 1.46
[Pneumococcal vaccination: conjugated vaccine induces herd immunity and reduces antibiotic resistance]. Dtsch Med Wochenschr (2008) 1.45
Pharmacodynamics of fluoroquinolones. Clin Infect Dis (1998) 1.42
Pharmacokinetics of amoxicillin and clavulanic acid administered alone and in combination. Antimicrob Agents Chemother (1982) 1.42
Azithromycin--review of key chemical, pharmacokinetic and microbiological features. J Antimicrob Chemother (1996) 1.40
Multiple-dose pharmacokinetics of ceftazidime and its influence on fecal flora. Antimicrob Agents Chemother (1983) 1.39
Antiviral treatment and prophylaxis of influenza in primary care: German recommendations. J Clin Virol (2004) 1.39
Mixed community-acquired pneumonia in hospitalised patients. Eur Respir J (2006) 1.29
Comparative pharmacokinetics of apalcillin and piperacillin. Antimicrob Agents Chemother (1984) 1.28
Characteristics and outcome of patients with active pulmonary tuberculosis requiring intensive care. Eur Respir J (2006) 1.28
Comparative effects of moxifloxacin and clarithromycin on the normal intestinal microflora. Scand J Infect Dis (2000) 1.27
[Comparative clinical pharmacology of gentamicin, sisomicin, and tobramycin]. Antimicrob Agents Chemother (1975) 1.26
Procalcitonin as a diagnostic tool in lower respiratory tract infections and tuberculosis. Eur Respir J (2003) 1.24
Pharmacokinetics of gatifloxacin and interaction with an antacid containing aluminum and magnesium. Antimicrob Agents Chemother (1999) 1.24
Comparative pharmacokinetics of new quinolones. Drugs (1987) 1.22
Determination of apalcillin and its metabolites in human body fluids by high-pressure liquid chromatography. Antimicrob Agents Chemother (1982) 1.19
Serum bactericidal activities and comparative pharmacokinetics of meropenem and imipenem-cilastatin. Antimicrob Agents Chemother (1996) 1.19
Septicemia in 980 patients at a university hospital in Berlin: prospective studies during 4 selected years between 1979 and 1989. Clin Infect Dis (1992) 1.17
Localized pulmonary infection associated with Mycobacterium tilburgii in an HIV-infected patient. Infection (2005) 1.12
Determination of cefmenoxime in human body fluids by high-performance liquid chromatography. Eur J Clin Microbiol (1983) 1.08
Multiple dose pharmacokinetics and therapeutic results with ceftazidime. J Antimicrob Chemother (1983) 1.07
Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research. Intensive Care Med (1997) 1.05
Amplification of Mycobacterium tuberculosis from peripheral blood. J Clin Microbiol (1995) 1.03
Toxicity of quinolones. Drugs (1999) 1.03
Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam. Antimicrob Agents Chemother (1983) 1.03
Multiple dose pharmacokinetics, safety, and effects on faecal microflora, of cefepime in healthy volunteers. J Antimicrob Chemother (1992) 1.02
Chlamydia pneumoniae as a cause of community-acquired pneumonia in hospitalized patients in Berlin. Clin Infect Dis (1996) 1.01
Pharmacokinetics of cefpodoxime proxetil and interactions with an antacid and an H2 receptor antagonist. Antimicrob Agents Chemother (1992) 1.00
Influence of ranitidine, pirenzepine, and aluminum magnesium hydroxide on the bioavailability of various antibiotics, including amoxicillin, cephalexin, doxycycline, and amoxicillin-clavulanic acid. Antimicrob Agents Chemother (1989) 1.00
Biliary excretion and pharmacokinetics of cefoperazone in humans. J Antimicrob Chemother (1983) 0.99
Elimination of ampicillin and gentamicin by hemofiltration. Klin Wochenschr (1979) 0.99
Measurement of lung density by computed tomography. J Comput Assist Tomogr (1978) 0.99
Lymphocyte subsets in peripheral blood and smoking habits. Lung (1997) 0.98
Cefotaxime in bronchopulmonary infections--a clinical and pharmacological study. J Antimicrob Chemother (1980) 0.98
Pharmacokinetics and serum bactericidal activity of vancomycin alone and in combination with ceftazidime in healthy volunteers. Antimicrob Agents Chemother (1988) 0.97
Rapid drug susceptibility testing of Mycobacterium tuberculosis using conventional solid media. Eur Respir J (1995) 0.97
Liquid chromatographic determination of ciprofloxacin and some metabolites in human body fluids. J Clin Chem Clin Biochem (1986) 0.97
Cells and cytokines in chronic bronchial infection. Ann N Y Acad Sci (1994) 0.96
[Clinical aspects of endocarditis]. Immun Infekt (1991) 0.96
Determination of sparfloxacin in serum and urine by high-performance liquid chromatography. J Chromatogr (1992) 0.96
[Blood levels of cephalothin in normal and impaired renal function]. Int Z Klin Pharmakol Ther Toxikol (1972) 0.96
Reduced spontaneous apoptosis in peripheral blood neutrophils during exacerbation of COPD. Eur Respir J (2004) 0.96
Meropenem: clinical response in relation to in vitro susceptibility. Clin Microbiol Infect (2000) 0.96
Carbapenems in clinical practice: a guide to their use in serious infection. Int J Antimicrob Agents (1999) 0.96
Pharmacokinetic and clinical studies with amikacin, a new aminoglycoside antibiotic. J Infect Dis (1976) 0.94
Immunogenity of the pneumococcal polysaccharide vaccine in COPD patients. The effect of systemic steroids. Respir Med (2004) 0.93
Concentrations of ofloxacin in human bone and in cartilage. J Antimicrob Chemother (1990) 0.92
Multiple-dose pharmacokinetics of sparfloxacin and its influence on fecal flora. Antimicrob Agents Chemother (1994) 0.92
Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumonia. Eur Respir J (2003) 0.92